Doxazosin and captopril in mildly hypercholesterolemic hypertensive patients. The Doxazosin-Captopril in Hypercholesterolemic Hypertensives Study.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  HYPERTENSION

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.HYP.21.1.97PMID 8418030
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Essential Hypertension: An Insulin‐Resistant State

  1990cited by this paper
• Cholesterol:phospholipid ratio is elevated in platelet plasma membrane in patients with hypertension.

  1990cited by this paper
• Factors influencing the lipid response to selective alpha 1-inhibition.

  1989cited by this paper
• Hypolipidemic effects of long-term antihypertensive treatment with captopril. A prospective study.

  1988cited by this paper
• Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension.

  1988cited by this paper
• [Treatment of hypertension associated with metabolic anomalies].

  1988cited by this paper
• Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.

  1988cited by this paper
• Effects of antihypertensives on plasma lipids and lipoprotein metabolism.

  1988cited by this paper
• Effect of doxazosin monotherapy on blood pressure and plasma lipids in patients with essential hypertension.

  1988cited by this paper
• Abnormalities of erythrocyte membrane fatty acid composition in human essential hypertension.

  1987cited by this paper
• Coronary risk prediction in adults (the Framingham Heart Study)

  1987cited by this paper
• The Prospective Cardiovascular Münster Study: prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension.

  1987cited by this paper
• Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the primary prevention trial in Göteborg, Sweden.

  1987cited by this paper
• Paediatric gastroenterology: lessons of inborn errors.

  1986cited by this paper
• Low dose captopril twice daily lowers blood pressure without disturbance of the normal circadian rhythm.

  1986cited by this paper
• The metabolism and kinetics of doxazosin in man, mouse, rat and dog.

  1986cited by this paper
• The effects of antihypertensive therapy on the quality of life.

  1986influential reference
• A population at risk: Prevalence of high cholesterol levels in hypertensive patients in the framingham study

  1986cited by this paper
• Associations of three erythrocyte cation transport systems with plasma lipids in Utah subjects.

  1986cited by this paper
• Low dose captopril twice daily lowers blood pressure without disturbance of the normal circadian rhythm.

  1986cited by this paper
• Effect of terazosin on serum lipids.

  1986cited by this paper
• Effects of alpha-adrenergic and beta-adrenergic receptor blockade on lipid metabolism.

  1986cited by this paper
• Radial-immunodiffusion assay of human apolipoprotein A-I with use of two monoclonal antibodies combined.

  1986cited by this paper
• Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.

  1985cited by this paper
• Development of a radial immunodiffusion technique employing monoclonal antibodies for apolipoprotein B determination in human plasma.

  1985cited by this paper
• Hypertension: psychological aspects and diagnostic impact in a clinical trial.

  1984cited by this paper
• Captopril: A Preliminary Review of its Pharmacological Properties and Therapeutic Efficacy

  1980cited by this paper
• Effect of propranolol and prazosin on blood lipids. The Oslo Study.

  1980cited by this paper
• EFFECT OF PROPRANOLOL AND PRAZOSIN ON BLOOD LIPIDS: The Oslo Study

  1980cited by this paper
• Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling project research group.

  1978cited by this paper
• Elevation of serum lipid levels during diuretic therapy of hypertension.

  1976cited by this paper
• Letter: Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation.

  1976cited by this paper
• Triglycerides Determination after Enzymatic Hydrolysis

  1974cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• The Effect of Methyl dopa on serum lipid profile in rat.

  2017cites this paper
• Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: comparison with Captopril.

  2011cites this paper
• Blood Pressure-Lowering Effect and Duration of Action of Bedtime Administration of Doxazosin Determined by Home Blood Pressure Measurement

  2010cites this paper
• Effect of amlodipine on serum lipid profilein hypertensive patients

  2009cites this paper
• Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.

  2007cites this paper
• Usefulness of the α1-Blocker Doxazosin as a Third-Line Antihypertensive Drug

  2007cites this paper
• [Systemic hypertension at emergency units. The use of symptomatic drugs as choice for management].

  2005cites this paper
• Lack of effect of captopril on the metabolism of an artificial lipid emulsion similar to chylomicrons in hypertensive hypercholesterolemic patients.

  2004cites this paper
• UNIVERSIDADE FEDERAL DE PERNAMBUCO CENTRO DE CIÊNCIAS DA SAÚDE PÓS-GRADUAÇÃO EM MEDICINA INTERNA

  2003cites this paper
• Exploration of the Relationship between Health-Related Quality of Life and the Price of Pharmaceutical Products

  2003cites this paper
• [Tonocardin in complex treatment of diabetes mellitus concurrent with hypertension].

  2002cites this paper
• Assessment of Quality of Life in a Double-Blind, Randomized Clinical Trial of Imidapril and Captopril for Hypertensive Chinese in Taiwan

  2002cites this paper
• Doxazosin Inhibits Monocyte Chemotactic Protein 1–Directed Migration of Human Monocytes

  2001cites this paper
• Health-Related Quality-of-Life Measurement in Hypertension

  2000influential citation
• Effects of a 3-month treatment with terazosin on fasting and postprandial glucose and lipid metabolism in type 2 diabetic patients with hypertension.

  1999cites this paper
• Hypertension in the ESRD patient: pathophysiology, therapy, outcomes, and future directions.

  1998cites this paper
• Clinical pharmacology of modern antihypertensive agents and their interaction with alpha-adrenoceptor antagonists.

  1998cites this paper
• IN-DEPTH REVIEW Hypertension in the ESRD Patient: Pathophysiology, Therapy, Outcomes, and Future Directions

  1998cites this paper
• BLOOD PRESSURE CONTROL AND CARDIOVASCULAR RISK IN PATIENTS OF INDO‐ASIAN AND AFRICAN‐CARIBBEAN DESCENT

  1998cites this paper
• The 32nd Annual Meeting of the European Association for the Study of Diabetes: Treatment of type I diabetes, hypoglycemia, retinopathy, nephropathy, and the genetics of complications

  1997cites this paper
• Effect of Bunazosin and Atenolol on Glucose Metabolism in Obese, Nondiabetic Patients with Primary Hypertension

  1997cites this paper
• Overview of alpha 1-adrenoceptor antagonism and recent advances in hypertensive therapy.

  1996cites this paper
• Mitochondrial Gene Abnormalities and α- and ²-Cell Dysfunction

  1996cites this paper
• Alpha blockers: a reassessment of their role in therapy.

  1996cites this paper
• Overview of α1-Adrenoceptor Antagonism and Recent Advances in Hypertensive Therapy

  1996cites this paper
• ACE Inhibitors in Elderly Patients with Hypertension

  1996cites this paper
• ACE inhibitors in elderly patients with hypertension. Special considerations.

  1996cites this paper
• Doxazosin lowers blood pressure and improves insulin responses to a glucose load with no changes in tyrosine kinase activity or insulin binding.

  1995cites this paper
• Postprandial intestinal-derived chylomicron and chylomicron remnants in essential hypertensive patients before and after prolonged captopril therapy.

  1995cites this paper
• Doxazosin Update of its Clinical Pharmacology and Therapeutic Applications in Hypertension and Benign Prostatic Hyperplasia

  1995cites this paper
• Factors affecting lipoprotein lipase in hypertensive patients.

  1995cites this paper
• Comparative and combined efficacy of doxazosin and enalapril in hypertensive patients.

  1994cites this paper
• Effects of doxazosin on blood pressure and serum lipid levels in hypertensive patients

  1994cites this paper
• Hyperinsulinemia, Insulin Resistance, and Hypertension

  1994cites this paper
• Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: the Alpha Beta Canada Study.

  1994cites this paper
• Effects of Doxazosin Mesilate on Blood Pressure and Serum Lipids inHypertensive Patients

  1994cites this paper
• Angiotensin-converting enzyme inhibitors in the treatment of mild arterial hypertension.

  1993cites this paper